11.07.2015 Views

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Iowa</strong><strong>Department</strong><strong>of</strong> <strong>Human</strong>Services<strong>Provider</strong> and Chapter<strong>Prescribed</strong> <strong>Drugs</strong>Chapter III. <strong>Provider</strong>-Specific PoliciesPage91DateAugust 1, 2013b. Reimbursement for FUL <strong>Drugs</strong>For the drug groups on the Preferred Drug List where brand-nameproducts are preferred over generic products, the FUL rate will continueto apply when the generic version <strong>of</strong> the drug is dispensed.However, the payment for preferred brand name products (which nolonger require prior authorization before dispensing) equals the lower <strong>of</strong>the average acquisition cost (average AAC) or the submitted charges, asopposed to the FUL/SMAC rate.Nonpreferred brand products require prior authorization beforedispensing. If authorized, payment equals the lower <strong>of</strong> the the averageacquisition cost (average AAC) or the submitted charges, as opposed tothe FUL rate with a prior authorization. The DAW=1 is no longerrequired for brand reimbursement.Prior authorization is required for selected brand-name drugs asdetermined by the <strong>Department</strong> for which there is available, an “A” ratedbioequivalent generic product as determined by the federal Food andDrug Administration.For prior authorization to be considered, evidence <strong>of</strong> a treatment failurewith the bioequivalent generic drug must be provided. A copy <strong>of</strong> acompleted form 470-4119, Request for Prior Authorization: SelectedBrand Name <strong>Drugs</strong>, shall be considered as evidence <strong>of</strong> treatment failure.The list <strong>of</strong> selected brand-name drugs includes the drugs on the FederalUpper Limit (FUL) list at http://mslciowa.com/AAC.htm. Priorauthorization is not required for brand name drugs that have beendesignated by the <strong>Department</strong> as preferred (payable) under the <strong>Iowa</strong>Medicaid Preferred Drug List (PDL).3. Reimbursement for Unit-Dose PackagingAdditional reimbursement <strong>of</strong> one cent per dose shall be added to theallowable ingredient cost <strong>of</strong> a prescription for an oral solid if the drug isdispensed to a patient in a nursing home in unit dose packaging prepared bythe pharmacist. Unit-dose reimbursements are permitted only for patientswith Plan 300 eligibility.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!